Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 36.170
- -0.380-1.04%
Close Feb 14 16:00 ET
- 36.210
- +0.040+0.11%
Post 20:01 ET
73.82BMarket Cap23.14P/E (TTM)
36.605High36.160Low4.54MVolume36.480Open36.550Pre Close165.04MTurnover0.23%Turnover Ratio23.14P/E (Static)2.04BShares44.86352wk High4.30P/B71.35BFloat Cap31.71552wk Low1.52Dividend TTM1.97BShs Float44.863Historical High4.21%Div YieldTTM1.22%Amplitude6.376Historical Low36.337Avg Price1Lot Size
GlaxoSmithKline Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | -44.40%2.95B | 25.88%501M | -95.76%65M | -25.27%1.3B | -33.72%1.08B | 7.86%5.31B | -75.51%398M | 96.92%1.53B | 133.91%1.75B | -7.91%1.63B |
| Deferred tax | -30.42%526M | 426.32%62M | -100.39%-1M | -21.07%191M | -0.72%274M | 6.93%756M | -2,000.00%-19M | 10.30%257M | 61.33%242M | -14.55%276M |
| Other non cash items | 16.38%547M | 1,092.86%139M | -21.52%124M | -1.32%150M | -22.99%134M | 34.29%470M | 93.30%-14M | -11.24%158M | -16.94%152M | -12.12%174M |
| Change In working capital | 674.18%2.09B | 63.08%3.76B | -551.22%-740M | 68.99%-618M | 62.98%-311M | -234.81%-364M | 146.00%2.31B | 137.61%164M | -903.63%-1.99B | -75.37%-840M |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | -5.36%-649M | ---- | ---- | ---- | ---- |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | -57.62%-424M | ---- | ---- | ---- | ---- |
| -Change in other current assets | ---175M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | 360.37%2.27B | ---- | ---- | ---- | ---- | -69.78%492M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.16%6.55B | -27.13%2.33B | -2.62%2.15B | -14.84%1.11B | 1,707.55%958M | -8.58%6.77B | 67.77%3.2B | 67.45%2.21B | -20.06%1.31B | -97.92%53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -3.73%-1.33B | -0.84%-483M | -5.56%-304M | -2.39%-300M | -9.29%-247M | -28.99%-1.29B | -57.05%-479M | -7.46%-288M | -23.63%-293M | -20.86%-226M |
| Net intangibles purchase and sale | -42.63%-1.45B | -97.31%-586M | -121.72%-439M | 39.83%-139M | 1.37%-288M | -10.77%-1.02B | -22.22%-297M | -115.22%-198M | -8.96%-231M | 21.51%-292M |
| Net business purchase and sale | 370.10%1.37B | -110.02%-96M | 76.71%-17M | 315.68%1.17B | 700.00%312M | 109.28%291M | 16,066.67%958M | 97.56%-73M | -632.43%-542M | 25.71%-52M |
| Net investment purchase and sale | -70.83%21M | --0 | -102.13%-1M | --0 | --22M | 7,100.00%72M | 2,400.00%25M | --47M | --0 | --0 |
| Net other investing changes | ---1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 22.95%-1.23B | -517.54%-1.12B | -48.88%-731M | 179.88%770M | 63.48%-149M | 81.82%-1.6B | 149.63%268M | 88.01%-491M | -76.88%-964M | 88.64%-408M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 50.80%-1.17B | 108.81%244M | 47.51%-548M | -152.03%-539M | -179.17%-323M | 48.72%-2.37B | -582.27%-2.77B | 9.30%-1.04B | 136.79%1.04B | 263.86%408M |
| Net common stock issuance | 100.00%20M | --0 | --1M | -66.67%1M | 200.00%18M | -60.00%10M | --1M | --0 | -57.14%3M | -40.00%6M |
| Cash dividends paid | -8.77%-2.44B | -7.75%-612M | -7.94%-612M | -17.06%-652M | -2.34%-568M | 35.19%-2.25B | 13.15%-568M | 19.57%-567M | 51.82%-557M | 41.70%-555M |
| Net other financing activities | -59.53%138M | -127.22%-43M | 1,337.50%99M | -27.87%44M | -70.77%38M | -96.74%341M | -36.80%158M | -100.94%-8M | 421.05%61M | -98.61%130M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 16.22%-4.73B | 76.56%-842M | 29.63%-1.24B | -5,209.68%-1.58B | -233.33%-1.06B | -785.42%-5.64B | -168.46%-3.59B | -32.88%-1.76B | 100.69%31M | -103.99%-318M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.55%2.86B | 0.26%3.03B | -5.23%2.88B | -4.89%2.59B | -16.55%2.86B | -10.32%3.43B | -9.90%3.02B | -59.09%3.04B | -74.69%2.72B | -10.27%3.43B |
| Current changes in cash | 227.99%599M | 387.50%368M | 546.34%183M | -20.05%299M | 62.70%-251M | 14.29%-468M | -574.07%-128M | 99.00%-41M | 111.01%374M | -109.72%-673M |
| Effect of exchange rate changes | 45.45%-54M | 120.59%7M | -247.83%-34M | 85.96%-8M | 38.71%-19M | -165.13%-99M | -173.91%-34M | 0.00%23M | -180.28%-57M | -358.33%-31M |
| End cash Position | 19.07%3.4B | 19.07%3.4B | 0.26%3.03B | -5.23%2.88B | -4.89%2.59B | -16.55%2.86B | -16.55%2.86B | -9.90%3.02B | -59.09%3.04B | -74.69%2.72B |
| Free cash flow | -19.26%3.57B | -50.52%1.19B | -23.50%1.31B | -13.08%671M | 182.98%395M | -14.01%4.42B | 109.10%2.41B | 103.92%1.72B | -34.47%772M | -124.14%-476M |
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
